Hyun Y. Yeo
Goyang, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Clonal evolution and mutational trajectories of metastatic colorectal cancer shaped by anticancer therapies.
Journal: Nature communications
Published: November 28, 2025
A pilot study of clinical evidence for phenotypic circulating tumor cell counts in stage II/III rectal cancer patients treated with neoadjuvant chemoradiotherapy.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: September 30, 2025
Fecal Microbial Dysbiosis Is Associated with Colorectal Cancer Risk in a Korean Population.
Journal: Cancer research and treatment
Published: April 18, 2024
The relationships between systemic cytokine profiles and inflammatory markers in colorectal cancer and the prognostic significance of these parameters.
Journal: British journal of cancer
Published: October 14, 2019
Association of CHFR Promoter Methylation with Treatment Outcomes of Irinotecan-Based Chemotherapy in Metastatic Colorectal Cancer.
Journal: Neoplasia (New York, N.Y.)
Published: October 03, 2018
Deleted in malignant brain tumor 1 is a novel prognostic marker in colorectal cancer.
Journal: Oncology reports
Published: October 19, 2017
A New Cell Block Method for Multiple Immunohistochemical Analysis of Circulating Tumor Cells in Patients with Liver Cancer.
Journal: Cancer research and treatment
Published: December 24, 2015
Dipeptidyl peptidase 10, a novel prognostic marker in colorectal cancer.
Journal: Yonsei medical journal
Published: October 22, 2013
Serpin B5 is a CEA-interacting biomarker for colorectal cancer.
Journal: International journal of cancer
Published: January 14, 2013
Last Updated: 09/26/2026